Skip to main content

Advertisement

Log in

Clinicopathologic Comparison of Siewert Type II and III Adenocarcinomas of the Gastroesophageal Junction

  • Published:
World Journal of Surgery Aims and scope Submit manuscript

Abstract

Background

Since Misumi et al. and Siewert proposed a new classification for carcinoma of the gastroesophageal junction (GEJ), few surgical studies using these criteria have been reported from Eastern countries. Siewert type II adenocarcinomas are managed using general rules for either gastric or esophageal cancer. We set out to determine whether type II adenocarcinoma is a distinct clinical entity requiring a more specific treatment plan.

Methods

Among 125 Japanese patients who underwent resection of adenocarcinoma of the GEJ (type I, 2; type II, 44; type III, 79), 101 who underwent R0 resections (type II, 40; type III, 61) were analyzed to evaluate surgical results and compare clinicopathologic factors.

Results

Barrett’s epithelium was recognized in two patients with type II adenocarcinoma. Type II differed significantly from type III in higher prevalence of Borrmann macroscopic type 2, more frequent lymph node metastasis (58% vs. 34%), higher metastatic rate to lower mediastinal lymph nodes (13%), increased risk of hepatic recurrence, and lower 5-year survival after R0 resection (67.4% vs. 87.1%).

Conclusions

Clinicopathologic differences were evident between type II and III adenocarcinomas. Siewert type II adenocarcinoma differs sufficiently to be considered a clinical entity distinct and independent from type III.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. Clark GW, Peters JH, Ireland AP, et al. Nodal metastasis and sites of recurrence after en bloc esophagectomy for adenocarcinoma. Ann Thorac Surg 1994;58:646–653

    CAS  PubMed  Google Scholar 

  2. Wright CD, Mathisen DJ, Wain JC, et al. Evolution of treatment strategies for adenocarcinoma of the esophagus and gastroesophageal junction. Ann Thorac Surg 1994;58:1574–1578

    CAS  PubMed  Google Scholar 

  3. Millikan KW, Silverstein J, Hart V, et al. A 15-year review of esophagectomy for carcinoma of the esophagus and cardia. Arch Surg 1995;130:617–624

    CAS  PubMed  Google Scholar 

  4. Tachimori Y, Kato H, Watanabe H, et al. Difference between carcinoma of the lower esophagus and the cardia. World J Surg 1996;20:507–510

    Article  CAS  PubMed  Google Scholar 

  5. Nishi M, Nomura H, Kajisa T, et al. Surgical problem of carcinoma in the esophagogastric junction (in Japanese with English abstract). Stomach and Intestine 1978;13:1497–1507

    Google Scholar 

  6. Nakane Y, Okamura S, Boku T, et al. Prognostic differences of adenocarcinoma arising from the cardia and the upper third of the stomach. Am Surg 1993;59:423–429

    CAS  PubMed  Google Scholar 

  7. Ohno S, Tomisaki S, Oiwa H, et al. Clinicopathologic characteristics and outcome of adenocarcinoma of the human gastric cardia in comparison with carcinoma of other regions of the stomach. J Am Coll Surg 1995;180:577–582

    CAS  PubMed  Google Scholar 

  8. Okabayashi T, Gotoda T, Kondo H, et al. Early carcinoma of the gastric cardia in Japan: is it different from that in the West? Cancer 2000;89:2555–559

    Article  CAS  PubMed  Google Scholar 

  9. Misumi A, Murakami A, Harada K, et al. Definition of carcinoma of the gastric cardia. Langenbecks Arch Chir 1989;374:221–226

    Article  CAS  PubMed  Google Scholar 

  10. Siewert JR, Stein HJ. Carcinoma of the cardia: carcinoma of the gastroesophageal junction―classification, pathology and extent of resection. Dis Esophagus 1996;9:173–182

    Google Scholar 

  11. Powell J, McConkey CC. Increasing incidence of adenocarcinoma of the gastric cardia and adjacent sites. Br J Cancer 1990;62:440–443

    CAS  PubMed  Google Scholar 

  12. Devesa SS, Blot WJ, Fraumeni JF Jr. Changing patterns in the incidence of esophageal and gastric carcinoma in the United States. Cancer 1998;83:2049–2053

    Article  CAS  PubMed  Google Scholar 

  13. Ozawa S, Ando N, Kitagawa Y, et al. Does incidence of carcinoma of the esophagogastric junction increase (in Japanese with English abstract)? Nippon Geka Gakkai Zasshi 1998;99:542–546

    CAS  PubMed  Google Scholar 

  14. Kodera Y, Yamamura Y, Shimizu Y, et al. Adenocarcinoma of the gastroesophageal junction in Japan: relevance of Siewert’s classification applied to 177 cases resected at a single institution. J Am Coll Surg 1999;189:594–601

    Article  CAS  PubMed  Google Scholar 

  15. Nakamura T, Ide H, Eguchi R, et al. Adenocarcinoma of the esophagogastric junction: a summary of responses to a questionnaire on adenocarcinoma of the esophagus and the esophagogastric junction in Japan. Dis Esophagus 2002;15:219–225

    Article  CAS  PubMed  Google Scholar 

  16. Ichikura T, Ogawa T, Kawabata T, et al. Is adenocarcinoma of the gastric cardia a distinct entity independent of subcardial carcinoma? World J Surg 2003;27:334–338

    PubMed  Google Scholar 

  17. Siewert JR, Feith M, Werner M, et al. Adenocarcinoma of the esophagogastric junction: results of surgical therapy based on anatomical / topographic classification in 1,002 consecutive patients. Ann Surg 2000;232:353–361

    Google Scholar 

  18. Mariette C, Castel B, Toursel H, et al. Surgical management of and long-term survival after adenocarcinoma of the cardia. Br J Surg 2002;89:1156–1163

    Article  CAS  PubMed  Google Scholar 

  19. Ito H, Clancy TE, Osteen RT, et al. Adenocarcinoma of the gastric cardia: what is the optimal surgical approach? J Am Coll Surg. 2004;199:880–886

    Article  PubMed  Google Scholar 

  20. Fein M, Fuchs KH, Ritter MP, et al. Application of the new classification for cancer of the cardia. Surgery 1998;124:707–713

    Article  CAS  PubMed  Google Scholar 

  21. Peracchia A, Bonavina L, Incarbone R, et al. Results of surgical therapy in patients with adenocarcinoma of the esophagus and cardia. Gastric Cancer 1999;2:89–94

    Article  PubMed  Google Scholar 

  22. Hulscher JB, Van Sandick JW, Offerhaus GJ, et al. Prospective analysis of the diagnostic yield of extended en bloc resection for adenocarcinoma of the esophagus or gastric cardia. Br J Surg 2001;88:715–719

    Article  CAS  PubMed  Google Scholar 

  23. Japanese Gastric Cancer Association. Japanese classification of gastric carcinoma, 2nd English edition. Gastric Cancer 1998;1:10–24

    Article  PubMed  Google Scholar 

  24. Sobin LH, Wittekind C, International Union Against Cancer. (UICC), eds, TNM Classification of Malignant Tumors. 5th ed. New York: John Wiley & Sons, Inc., 1997

  25. Fleming ID, American Joint Committee on Cancer Classification (AJCC), eds, AJCC Cancer Staging Manual. Philadelphia: Lippincott Williams & Wilkins, 1997

  26. Akiyama H, Miyazono H, Tsurumaru M, et al. Thoracoabdominal approach for carcinoma of the cardia of the stomach. Am J Surg 1979;137:345–349

    Article  CAS  PubMed  Google Scholar 

  27. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457–481

    Google Scholar 

  28. Gehan EA. A generalized Wilcoxon test for comparing arbitrarily singly-censored samples. Biometrika 1965;52:203–224

    PubMed  Google Scholar 

  29. Dresner SM, Lamb PJ, Bennett MK, et al. The pattern of metastatic lymph node dissemination from adenocarcinoma of the esophagogastric junction. Surgery 2001;129:103–109

    Article  CAS  PubMed  Google Scholar 

  30. Aikou T, Shimazu H. Difference in main lymphatic pathways from the lower esophagus and gastric cardia. Jpn J Surg 1989;19:290–295

    CAS  PubMed  Google Scholar 

  31. De Manzoni G, Pedrazzani C, Pasini F, et al. Pattern of recurrence after surgery in adenocarcinoma of the gastroesophageal junction. Eur J Surg Oncol 2003;29:506–510

    PubMed  Google Scholar 

  32. Sadahiro S, Suzuki T, Ishikawa K, et al. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Cancer 2004;100:590–597

    Article  CAS  PubMed  Google Scholar 

  33. Sons HU, Borchard F. Cancer of the distal esophagus and cardia. Incidence, tumorous infiltration, and metastatic spread. Ann Surg 1986;203:188–195

    CAS  Google Scholar 

  34. Husemann B. Cardia carcinoma considered as a distinct clinical entity. Br J Surg 1989;76:136–139

    CAS  PubMed  Google Scholar 

  35. Stipa S, Di Giorgio A, Ferri M. Surgical treatment of adenocarcinoma of the cardia. Surgery 1992;111:386–393

    CAS  PubMed  Google Scholar 

  36. Mattioli S, Di Simone MP, Ferruzzi L, et al. Surgical therapy for adenocarcinoma of the cardia: modalities of recurrence and extension of resection. Dis Esophagus 2001;14:104–109

    Article  CAS  PubMed  Google Scholar 

  37. Heidl G, Langhans P, Mellin W, et al. Adenocarcinomas of esophagus and cardia in comparison with gastric carcinoma. J Cancer Res Clin Oncol 1993;120:95–99

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norihiro Yuasa MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yuasa, N., Miyake, H., Yamada, T. et al. Clinicopathologic Comparison of Siewert Type II and III Adenocarcinomas of the Gastroesophageal Junction. World J. Surg. 30, 364–371 (2006). https://doi.org/10.1007/s00268-005-0434-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00268-005-0434-x

Keywords

Navigation